Eshbal Initiates Non-Brokered Private Placement Offering
TSXV: ESBL
Eshbal Functional Food Inc. (TSXV: ESBL) is excited to announce a non-brokered private placement offering. This initiative aims to issue up to 4,411,765 units at a price of $0.17 each, targeting gross proceeds of approximately $750,000. Each Unit will comprise a common share and a warrant, providing both immediate capital and potential future equity boosts through the warrants.
Details of the Offering
The private placement units consist of one common share and one full purchase warrant, allowing the purchaser to acquire an additional common share at an exercise price of $0.30. This opportunity will remain open for twenty-four months following the closing date, which is anticipated to occur around January 29, 2026, subject to necessary approvals.
Eshbal plans to leverage the net proceeds from this offering to explore acquisition opportunities, enhance product development, advance sales initiatives, and ensure healthy working capital. The goal is to foster growth in the gluten-free food sector, a market segment where Eshbal sees substantial potential.
Complying with Regulations
The offering will adhere to applicable exemptions from the prospectus requirements across Canada and other international markets. These measures ensure that Eshbal meets legal standards while simplifying the investment process in this exciting phase.
Incentives for Participation
Furthermore, Eshbal may offer fees to finders involved in this private placement, which may include finder's warrants if permitted by the TSX Venture Exchange policies. These finder's warrants will carry similar terms to the purchase warrants being issued, encouraging broader participation in the offering.
About Eshbal Functional Food
Eshbal Functional Food is at the forefront of the food-tech industry, focusing on gluten-free and "Better for You" products. The company is implementing a roll-up strategy within the fragmented gluten-free market to build a robust platform capable of meeting the demands of major grocery retailers. A recent arrangement with Dare 2 be Different Foods is instrumental, as it positions Eshbal to potentially distribute its innovative products through Walmart and over 300 other stores in the Northeastern region of the U.S.
Future Prospects
Looking ahead, this offering equips Eshbal with the financial resources needed for its strategy, which revolves around innovation and customer needs in the gluten-free segment. By attracting investment, Eshbal aims to reinforce its market presence and develop products that align with consumer preferences for healthier food options.
Frequently Asked Questions
What is Eshbal’s current capital-raising initiative?
Eshbal is initiating a private placement offering to raise up to $750,000 through the sale of units, which include common shares and warrants.
What will the proceeds from the offering be used for?
The funds will be allocated for acquisition opportunities, ongoing product development, sales initiatives, and general working capital.
When is the expected closing date for the offering?
The offering is expected to close around January 29, 2026, pending necessary approvals.
How are the units structured in this placement?
Each unit consists of one common share and one warrant, allowing purchase of an additional common share at a specified price.
What makes Eshbal different in the food-tech sector?
Eshbal focuses on gluten-free and health-oriented products, aiming to create a scalable and efficient platform through strategic acquisitions.
